Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 5/1999

01-11-1999 | Review Article

Comparative Tolerability of the Newer Fluoroquinolone Antibacterials

Authors: Dr Peter Ball, Lionell Mandell, Yoshihito Niki, Glenn Tillotson

Published in: Drug Safety | Issue 5/1999

Login to get access
Metadata
Title
Comparative Tolerability of the Newer Fluoroquinolone Antibacterials
Authors
Dr Peter Ball
Lionell Mandell
Yoshihito Niki
Glenn Tillotson
Publication date
01-11-1999
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 5/1999
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199921050-00005

Other articles of this Issue 5/1999

Drug Safety 5/1999 Go to the issue

Review Article

A Risk-Benefit Assessment of Intra-Articular Corticosteroids in Rheumatic Disorders

Review Article

Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy

Review Article

A Risk-Benefit Assessment of Amifostine in Cytoprotection

Current Opinion

Levodopa in Parkinson’s Disease

Correspondence

The authors reply

Correspondence

Immunisation and Type 1 Diabetes Mellitus: Is There a Link?